Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma

PURPOSE: In 2015, the World Health Organization renamed mucinous bronchioloalveolar adenocarcinoma as pulmonary invasive mucinous adenocarcinoma (IMA). Due to its low incidence and unclear prognosis with surgical treatment, previous studies have presented opposing survival outcomes. We aimed to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Dongyu, Xie, Shaonan, Liu, Qingyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830770/
https://www.ncbi.nlm.nih.gov/pubmed/36624430
http://dx.doi.org/10.1186/s12890-023-02305-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830770/
https://www.ncbi.nlm.nih.gov/pubmed/36624430
http://dx.doi.org/10.1186/s12890-023-02305-x

Ejemplares similares